The Long Case For Reata Pharmaceuticals, Inc. (RETA)

The Long Case For Reata Pharmaceuticals, Inc. (RETA)

Reata Pharmaceuticals, Inc. (NASDAQ:RETA) is an interesting stock at present. Now trading with a market value of 4.27B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.

Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The […]

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.